Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Hematology
•
General Rheumatology
•
Dermatology
•
Pediatric Rheumatology
What is your approach to treatment in patients with cutaneous mastocytosis and inflammatory arthritis?
Related Questions
How would you approach management of an elderly patient with known mantle cell lymphoma and new diagnosis of cryoglobulinemic vasculitis with mild skin involvement, fatigue, arthralgias but no other major organ involvement?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
How do you approach managing nausea and GI side effects when initiating methotrexate?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
Can lupus anticoagulant be positive despite a normal aPTT?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
How would you approach management of a young male patient with discoid lupus who has had minimal response to hydroxychloroquine (and subtherapeutic whole blood levels) who continues to use tobacco products?
For patients with VEXAS syndrome and good response to azacitidine, what duration of therapy do you consider?
